Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The structure of heneicomycin.

R S Dewey1, O D Hensens, A W Douglas

  • 1Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065.

The Journal of Antibiotics
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 vaccination: public preference and intention in Vietnam.

Annali di igiene : medicina preventiva e di comunita·2022
Same author

Perspectives on COVID-19 prevention and treatment using herbal medicine in Vietnam: A cross-sectional study.

Annali di igiene : medicina preventiva e di comunita·2021
Same author

Cochlear implant user perceptions of magnetic resonance imaging.

Cochlear implants international·2021
Same author

Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK.

The Journal of antibiotics·2000
Same author

Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.

Biochemistry·1999
Same author

8-O-acetylharpagide is a nonsteroidal ecdysteroid agonist.

Insect biochemistry and molecular biology·1996

Heneicomycin, a novel elfamycin antibiotic, was discovered from Streptomyces filipinensis. This deoxy modification of aurodox lacks a hydroxyl group, distinguishing it from its known relative.

Area of Science:

  • Microbiology
  • Natural Products Chemistry
  • Organic Chemistry

Background:

  • Streptomyces species are prolific producers of diverse bioactive compounds, including antibiotics.
  • The elfamycin family comprises potent antibiotics with unique chemical structures.
  • Aurodox is a known member of the elfamycin antibiotic family.

Purpose of the Study:

  • To isolate and characterize a novel antibiotic from Streptomyces filipinensis.
  • To determine the chemical structure of the isolated compound.
  • To compare the novel compound with known elfamycin antibiotics, specifically aurodox.

Main Methods:

  • Isolation of the antibiotic from microbial cultures.
  • Mass spectral analysis for molecular weight and fragmentation patterns.

Related Experiment Videos

  • Nuclear Magnetic Resonance (NMR) spectroscopy for structural elucidation, including 1H NMR couplings.

    • Main Results:

    • Heneicomycin (1) was isolated as an amorphous yellow powder.
    • Mass spectral and NMR data identified heneicomycin as a deoxy modification of aurodox (2).
    • Key spectral differences, including mass spectral fragmentation and 1H NMR couplings, indicated the absence of a hydroxyl group at position 30 (or position 3 of the tetrahydropyran ring) compared to aurodox.

    Conclusions:

    • Heneicomycin is a newly identified member of the elfamycin antibiotic family.
    • The structural difference, specifically the deoxy modification, distinguishes heneicomycin from aurodox.
    • Further studies are warranted to explore the biological activity and potential applications of heneicomycin.